Eli Vlaisavljevich joined Virginia Tech’s “Curious Conversations” to talk about histotripsy, a novel ultrasound therapy for cancer treatment. He explained the mechanics of how histotripsy works, its clinical applications, and the body's immune response to tumor liquefaction. Vlaisavljevisch also shared insights related to the development of histotripsy devices, patient experiences, and future directions in cancer treatment.
About Vlaisavljevich
Eli Vlaisavljevich an associate professor in the Department of Biomedical Engineering and Mechanics. His research interests include biomaterials, biomechanics, biomedical imaging, nanobioengineering and tissue engineering. Vlaisavljevich also leads the Therapeutic Ultrasound and Non-Invasive Therapies Laboratory in investigating the physical mechanisms with which ultrasound interacts with tissue in order to develop non-invasive therapies for a wide range of clinical applications.
